⸺ Synova Research
AHK-Cu
Copper-binding peptide studied for hair-follicle growth, extracellular matrix remodelling and skin-repair signalling.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About AHK-Cu
AHK-Cu is a short copper peptide (Ala-His-Lys) investigated for its role in dermal papilla cell signalling, hair-follicle development and collagen-related repair pathways. Researchers use it alongside GHK-Cu to compare copper-peptide activity in skin and hair biology models.
⸺ Mechanism of Action
How it works
AHK-Cu binds copper ions and modulates signalling in dermal papilla and fibroblast cells. In vitro studies suggest it up-regulates growth factors and extracellular-matrix components involved in hair-follicle cycling and tissue remodelling.
⸺ Research
Areas of study
Hair-follicle biology
In vitro research on dermal papilla cells indicates AHK-Cu may support expression of growth factors linked to hair-follicle development and cycling.
Collagen and matrix remodelling
Studies report increased collagen and elastin-related gene expression, supporting investigation into skin-repair and anti-ageing mechanisms.
Copper-peptide comparisons
Preclinical work compares AHK-Cu with GHK-Cu to evaluate differences in copper delivery, cell-penetration efficiency and dermal signalling outcomes.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- 155149-63-4
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Sterile technique throughout.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.